SMN1 and proximal spinal muscular atrophy: The promise of AAV9 serotype carrying human SMN1 in improving survival and motor functions of wheelchair-bound children with spinal muscular atrophy (SMA) (Mendell et al., 2017) spurred translation of several explorative research to clinical trials for neurodegenerative diseases with AAVs.